Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity.
Pohl MO; Martin-Sancho L; Ratnayake R; White KM; Riva L; Chen QY; Lieber G; Busnadiego I; Yin X; Lin S; Pu Y; Pache L; Rosales R; Déjosez M; Qin Y; De Jesus PD; Beall A; Yoh S; Hale BG; Zwaka TP; Matsunaga N; García-Sastre A; Stertz S; Chanda SK; Luesch H.
ACS Infect Dis
(Unknown)
Published: 2022
Tuberculostearic Acid-Containing Phosphatidylinositols as Markers of Bacterial Burden in Tuberculosis.
Brandenburg J; Heyckendorf J; Marwitz F; Zehethofer N; Linnemann L; Gisch N; Karaköse H; Reimann M; Kranzer K; Kalsdorf B; Sanchez-Carballo P; Weinkauf M; Scholz V; Malm S; Homolka S; Gaede KI; Herzmann C; Schaible UE; Hölscher C; Reiling N; Schwudke D.
ACS Infect Dis
(Unknown)
Published: 2022
Effects of Structurally Different HDAC Inhibitors against <i>Trypanosoma cruzi</i>, <i>Leishmania</i>, and <i>Schistoso…
Di Bello E; Noce B; Fioravanti R; Zwergel C; Valente S; Rotili D; Fianco G; Trisciuoglio D; Mourão MM; Sales P; Lamotte S; Prina E; Späth GF; Häberli C; Keiser J; Mai A.
ACS Infect Dis
(Unknown)
Published: 2022
Structure-Based Design of α-Substituted Mercaptoacetamides as Inhibitors of the Virulence Factor LasB from <i>Pseudomon…
Kaya C; Walter I; Alhayek A; Shafiei R; Jézéquel G; Andreas A; Konstantinović J; Schönauer E; Sikandar A; Haupenthal J; Müller R; Brandstetter H; Hartmann RW; Hirsch AKH.
ACS Infect Dis
(Unknown)
Published: 2022
A Highly Potent SARS-CoV-2 Blocking Lectin Protein.
Ahan RE; Hanifehnezhad A; Kehribar EŞ; Oguzoglu TC; Földes K; Özçelik CE; Filazi N; Öztop S; Palaz F; Önder S; Bozkurt EU; Ergünay K; Özkul A; Şeker UÖŞ.
ACS Infect Dis
(Unknown)
Published: 2022
Identification of β-Lactams Active against <i>Mycobacterium tuberculosis</i> by a Consortium of Pharmaceutical Companie…
Gold B; Zhang J; Quezada LL; Roberts J; Ling Y; Wood M; Shinwari W; Goullieux L; Roubert C; Fraisse L; Bacqué E; Lagrange S; Filoche-Rommé B; Vieth M; Hipskind PA; Jungheim LN; Aubé J; Scarry SM; McDonald SL; Li K; Perkowski A; Nguyen Q; Dartois V; Zimmerman M; Olsen DB; Young K; Bonnett S; Joerss D; Parish T; Boshoff HI; Arora K; Barry CE; Guijarro L; Anca S; Rullas J; Rodríguez-Salguero B; Martínez-Martínez MS; Porras-De Francisco E; Cacho M; Barros-Aguirre D; Smith P; Berthel SJ; Nathan C; Bates RH.
ACS Infect Dis
(Unknown)
Published: 2022
Exotoxin-Targeted Drug Modalities as Antibiotic Alternatives.
ACS Infect Dis
(Unknown)
Published: 2022